ABSTRACT Physicians and other clinicians could help educate patients about hazardous environmental exposures, especially to substances that could affect their reproductive health. But the relevant scientific evidence is voluminous, of variable quality, and largely unfamiliar to health professionals caring for people of childbearing age. To bridge this gap between clinical and environmental health, we created a methodology to help evaluate the quality of evidence and to support evidence-based decision making by clinicians and patients. The methodology can also support professional societies, health care organizations, government agencies, and others in developing prevention-oriented guidelines for use in clinical and policy settings.
W idespread exposure to environmental chemicals at levels encountered in daily life can affect reproductive and developmental health adversely. 1, 2 Studies have demonstrated that the levels of chemicals to which an average person is exposed can prevent genes from functioning normally and interfere with the hormonal regulation critical to healthy reproduction. 3, 4 For example, environmental chemicals such as polybrominated diphenyl ethers (PBDEs) from flame retardants in furniture and computers, 5 phthalates in commonly used plastics, 2 and persistent organochlorine pesticides such as DDT 6, 7 share the ability to alter the endocrine, neurological, and other biological systems. Virtually everyone in the United States is constantly exposed to these and many other toxic chemicals found in homes, communities, and workplaces. 8, 9 Exposures to ambient levels of environmental chemicals during critical periods of growth and development-in utero and during infancy, childhood, and adolescence-are of particular concern because they can have a profound and lasting effect on health. [10] [11] [12] Virtually all pregnant women in the United States have detectable levels of all of the following environmental chemicals in their bodies: lead, mercury, toluene, perchlorate, bisphenol A (BPA), and some phthalates, pesticides, perfluorochemicals (PFCs), polychlorinated biphenyls (PCBs), and PBDEs. Studies have documented that each of these chemicals can be harmful to human reproduction or development, or both. Many of these chemicals in pregnant women are at levels associated with adverse health outcomes in human studies. 13 The reproductive and other potential health impacts of daily and simultaneous exposure to environmental chemicals has not been studied. This shortcoming is recognized by the National Academies to be a gap in current scientific methodologies that inform public policy. 1 Based on their expert assessment of the strength of the existing science, leading scientists and reproductive and other health care professionals recommend timely action to prevent harm. 11, [14] [15] [16] The evidence of harm for some chemicals is also strong enough to warrant regulatory action to reduce or prevent exposure, albeit after the chemicals have been allowed to enter the market, the environment, and people. 17 The inadequacy of this postmarket regulatory framework is receiving increased scrutiny by the federal government, 18 nongovernmental organizations, 19 industry, 20 and professional medical organizations. 21 
Intervening In Clinical Settings To Prevent Harm
Although efforts to improve the regulatory framework for chemicals in commerce are fundamental to preventing harm, the clinical practice of physicians and others offers a complementary point of intervention. Clinical practice presents an opportunity to identify and evaluate factors that influence patients' health and to counsel them about those factors, thus preventing harm from hazardous environmental exposures.
Pediatricians have long been attuned to this opportunity. The American Academy of Pediatrics has had an environmental health committee for more than half a century and publishes a clinician handbook for the prevention of childhood diseases linked to environmental exposures. 22 The Centers for Disease Control and Prevention and the Environmental Protection Agency (EPA) support a network of pediatric environmental health specialty units across the country. 23 These specialty units respond to requests for information throughout North America on prevention, diagnosis, management, and treatment of environmentally related health effects in children.
In light of the importance of preconception and prenatal environmental exposures to the health of the pregnancy, and thus to tomorrow's children and adults, these pediatric approaches to incorporating environmental health into clinical care are equally relevant to reproductive health. Many people hoping to have children are intensely and justifiably interested in the impact of environmental exposures on their pregnancies and the health of their future children. Health care professionals serving people of childbearing age can serve as a science-based source of guidance on how to avoid potentially adverse exposures. 24 More important, many people who may eventually have or want to have children are unaware that their home, workplace, and community environments may influence their fertility and their future children's health, and they do not know about steps they can take to reduce exposure and potential harm. Environmental health science provides much evidence about the contribution of the environment to reproductive health, but this information is not available to clinicians in a readily usable form.
One factor that makes it difficult for clinicians, patients, and policy makers to make use of the science is that it is not systematically and transparently evaluated and synthesized in a timely manner. The scientific evidence is voluminous, of variable quality, and largely unfamiliar to health professionals caring for people of childbearing age. And there is no trusted ready reference or compendium that provides health professionals and patients with timely, evidencebased advice about exposure to environmental contaminants.
There are many steps and complexities involved in the use of current best evidence in health care settings. 25 However, the process can be accelerated when knowledge-based information is readily available. 26 Therefore, we undertook an interdisciplinary collaborative process to develop a transparent and systematic methodology to sort out the scientific evidence linking environmental exposures to reproductive health outcomes. Although its purpose is to support the development of preventionoriented guidelines for use in clinical settings, the methodology can also be used to review the evidence in broader policy arenas.
Bridging The Gap Between Environmental Health And Clinical Sciences
Timely incorporation of scientific evidence into clinical care to improve health outcomes has long been a goal in the clinical arena, exemplified by the establishment of the Agency for Healthcare Research and Quality. 27 The experience gained in advancing this goal is directly relevant to incorporating environmental health science into clinical practice.
Currently, environmental health scientists use many different methodologies based on expert opinions to sort out the science. Historically, the clinical field generally relied on a system of expert reviews on which to base treatment decisions. 28 However, starting in the 1970s, the role of expert reviews began to be questioned, and systematic approaches that harness expertise to a rigorous, transparent, and explicit methodology to evaluate a clearly formulated question were advanced.
Landmark papers published in the clinical literature, such as the work of Elliott Antman and colleagues, 27 demonstrated the superiority of systematic reviews for patient outcomes. 28 Antman and colleagues compared recommendations based on expert opinions for treatment of myocardial infarction that had been published in scientific reviews and clinical textbooks to statistical analyses of the combined results of randomized controlled trials. This research documented the lack of timely incorporation of experimental evidence into expert-based recommendations: Some reviewers did not mention effective therapies, and others recommended therapies already proven to be ineffective.
In response to these and other similar research findings, by 2002 at least 121 methodologies of varying usefulness had been developed to evaluate health care research to guide clinical decision making. 29 Subsequently, attempts were made to address the limitations of many of these methods and the related concern that the abundance of methodologies could lead to confusion rather than clarity. 30, 31 An approach emerged-the Grading of Recommendations, Assessment, Development, and Evaluation (GRADE) system-that was based on contemporary principles of evidence-based medicine and that built on the strengths of existing systems and addressed their shortcomings. 32, 33 GRADE systematically rates the quality of evidence and grades the strength of the recommendations to administer-or not administer-an intervention based on the trade-offs between benefits, on the one hand, and risks, burden, and potential costs, on the other hand. Grading recommendations provides health care decision makers with a qualitative estimate of how good the recommendations are-strong or weak, with "weak" sometimes called "discretionary."
Thus, GRADE provided our effort to bridge the gap between clinical and environmental health sciences with a well-developed and transparent organizing framework to use in evaluating the strength of evidence, integrating expertise and patients' values and preferences, and effectively communicating the results. GRADE is also in wide use, having been adopted by more than fifty organizations such as the World Health Organization, the Agency for Healthcare Research and Quality, the Centers for Disease Control and Prevention, and Kaiser Permanente.
However, along with these strengths, GRADE and other evidence-based medicine methodologies have limitations in terms of their direct applicability to environmental health science. These limitations exist because clinical evidence differs in character from evidence streams in environmental science, and because clinical decision making differs in context from decision making in environmental health science. Each of these two essential differences is described below.
Evidence-Stream Differences Differences exist between clinical and environmental health sciences in the types of evidence generally available to decision makers. The GRADE method considers only human experimental and observational evidence. This is because in vitro and in vivo data have been accounted for by regulatory processes prior to the entry of pharmaceuticalsa primary application of GRADE-into the marketplace (Exhibit 1).
In contrast, clinicians cannot assume, as they do with pharmaceuticals, that adequate in vitro and in vivo testing of environmental contaminants has been undertaken and considered by regulatory agencies before widespread human exposure occurs. The vast majority of chemicals in commerce have entered the marketplace without comprehensive and standardized information on their reproductive or other chronic toxicities (Exhibit 1).
Decision-Context Differences Environmental and clinical sciences also differ in how decisions to expose populations and patients are made. GRADE rates the quality of evidence about exposure to exogenous substances based on how reliably the evidence informs a clinical riskbenefit decision. 34 This is consistent with regulatory and medical ethical requirements that human exposure to pharmaceuticals not occur in the absence of some potential benefit greater than the known risks.
The "gold standard" for informing clinical risk-benefit decisions about medical interventions is a well-conducted randomized controlled trial. There is no comparable comprehensive weighing of health benefits and risks in the environmental arena. 35 The benefits of environmental chemicals are mostly not directed toward improving health, and exposures vary and may or may not be significant depending on the toxicity of the agent. Randomized controlled trials on environmental contaminants are virtually precluded from the evidence stream because of ethical considerations.
The Navigation Guide
To bridge this gap between the evidence streams and decision contexts in clinical and environmental health sciences, we undertook an interdisciplinary collaboration to craft an evidencebased medicine methodology for evaluating environmental contaminants and their potential effects on reproductive and developmental health. The result is the Navigation Guide, the product of a year-long collaboration of twentytwo clinical practitioners and environmental health scientists from governmental and nongovernmental organizations in the United States and Europe.
The Navigation Guide proceeds from GRADE but accounts for the differences in evidence and decision context described above. The method is briefly summarized here and presented in detail in the Appendix. 36 The methodology involves four steps.
Specify The Study Question The first step is to frame a specific question relevant to health care decision makers about whether human exposure to a chemical or class of chemicals is a reproductive health risk. An example would be, "Does maternal exposure to perfluorooctane sulfonate affect fetal growth?" Select The Evidence The next step involves conducting and documenting a systematic search for published and unpublished evidence. The Navigation Guide does not incorporate most existing lists of reproductive or developmental toxicants because the methods used to compile these lists are many and varied, and typically not systematic or transparent.
Rate The Evidence Consistent with GRADE, the Navigation Guide systematically rates the quality of individual studies and the quality of the overall body of evidence based on a priori and clearly stated criteria. However, because of the nature of the evidence stream in environmental health, the Navigation Guide conducts this process for studies of humans as well as for studies of laboratory animals and other nonhuman streams of evidence.
As a consequence, the methodology involves an additional step to integrate the quality ratings of each of these two streams of evidence. The result is one of five possible statements about the overall strength of the evidence pertaining to a particular environmental exposure: "known to be toxic," "probably toxic," "possibly toxic," "not classifiable," or "probably not toxic" to reproductive or developmental health.
Grade The Strength Of The Recommendations In the final step, the Navigation Guide integrates the strength of the evidence on toxicity with information about exposure, the availability of a less toxic alternative, and patients' values and preferences.
The result of applying the Navigation Guide is a concise, evidence-based recommendation for prevention, based on all of these considerations, such as, "Chemical X is known to be toxic to reproductive health. Doing x, y, or z to prevent exposure is strongly recommended. Doing a, b, or c is discretionary." 
Future Directions
A large body of science links exposure to environmental chemicals to adverse reproductive health outcomes across the lifespan of individuals and generations. Thus, there is enormous potential to reduce harm and associated health costs by bridging the divide that too often separates clinical and environmental health sciences. To this end, the Navigation Guide offers a methodology to vet the science linking environmental exposure to chemicals to reproductive and developmental health in a systematic and transparent way. Professional societies, health care organizations, government agencies, and other potential guideline developers, working with toxicologists, can use the Navigation Guide to craft consistent and timely recommendations to improve health outcomes for patients, and ultimately populations.
The evidence stream is rapidly changing in both clinical and environmental health sciences. The Navigation Guide and other evidence-based systems will need constant review to ensure that the most current approaches to identifying the evidence are rapidly incorporated and evaluated.
It is also expected that electronic health records will revolutionize medical research by facilitating the compilation of both instant data and longitudinal data. 37 Having such information could greatly accelerate the creation of knowledge about the impact of the environment on human health.
Conclusion
Just as the thalidomide tragedy of the 1950s and 1960s led to strengthened regulatory oversight of the safety and efficacy of all prescription drugs, 38 recent advances in testing for toxicity, [39] [40] [41] [42] [43] [44] in understanding the health risks of exposure to environmental contaminants, 1,2, 45, 46 and in the regulation of chemicals in commerce [18] [19] [20] [21] 47 are likely to result in important changes in the amount, type, and availability of data on chemical toxicity and related health impacts. We need to be able to translate these data in a timely way into prevention-oriented guidelines for use by clinicians and patients. The Navigation Guide provides a framework for doing so, with the ultimate goal of improving patient and population health. ▪ Woodruff is also the lead author of another paper in this issue that details the weaknesses in current approaches to prevent environmental contamination of foods and recommends incorporating environmental science into risk-management decisions. She is a coauthor on another paper for which Sutton is the lead author: a call to armsaimed in part at the health care community-to advance production of healthy foods to prevent adverse reproductive health effects.
